Junhui Sun

2.5k total citations · 1 hit paper
68 papers, 1.1k citations indexed

About

Junhui Sun is a scholar working on Hepatology, Molecular Biology and Surgery. According to data from OpenAlex, Junhui Sun has authored 68 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Hepatology, 19 papers in Molecular Biology and 15 papers in Surgery. Recurrent topics in Junhui Sun's work include Hepatocellular Carcinoma Treatment and Prognosis (30 papers), Liver Disease Diagnosis and Treatment (10 papers) and Renal cell carcinoma treatment (8 papers). Junhui Sun is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (30 papers), Liver Disease Diagnosis and Treatment (10 papers) and Renal cell carcinoma treatment (8 papers). Junhui Sun collaborates with scholars based in China, Madagascar and United States. Junhui Sun's co-authors include Guan‐Hui Zhou, Shusen Zheng, Chun‐Hui Nie, Fuliang Li, Zhen Huang, Jiping Wang, Rong Tang, Liangliang Qiao, Guoying Wang and Baogang Peng and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Nano Letters.

In The Last Decade

Junhui Sun

64 papers receiving 1.1k citations

Hit Papers

Lenvatinib Combined With Transarterial Chemoembolization ... 2022 2026 2023 2024 2022 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Lenvatinib Combined With Transarterial Chemoembolization as First-Line Treatment for Advanced Hepatocellular Carcinoma: A Phase III, Randomized Clinical Trial (LAUNCH)
    2022 262 citations Zhenwei Peng, Wenzhe Fan et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junhui Sun China 17 567 218 211 207 196 68 1.1k
Yoshiyuki Kobayashi Japan 21 595 1.0× 268 1.2× 424 2.0× 200 1.0× 222 1.1× 54 1.3k
Yasuji Ryu Japan 16 690 1.2× 226 1.0× 373 1.8× 242 1.2× 134 0.7× 30 1.1k
Ning Lyu China 19 488 0.9× 503 2.3× 170 0.8× 214 1.0× 284 1.4× 70 1.4k
Yasuo Ejima Japan 20 225 0.4× 332 1.5× 210 1.0× 205 1.0× 394 2.0× 49 1.3k
Jiliang Qiu China 21 655 1.2× 525 2.4× 351 1.7× 255 1.2× 260 1.3× 65 1.5k
Hanako Tsujikawa Japan 15 466 0.8× 334 1.5× 333 1.6× 142 0.7× 247 1.3× 37 1.2k
Maarten W. Nijkamp Netherlands 17 361 0.6× 346 1.6× 119 0.6× 291 1.4× 126 0.6× 51 1.1k
Florian Castet Spain 8 482 0.9× 437 2.0× 243 1.2× 107 0.5× 379 1.9× 20 1.4k
Shunli Shen China 22 480 0.8× 434 2.0× 305 1.4× 336 1.6× 275 1.4× 58 1.4k
Jimmy Yuen Hong Kong 10 592 1.0× 131 0.6× 287 1.4× 230 1.1× 122 0.6× 12 868

Countries citing papers authored by Junhui Sun

Since Specialization
Citations

This map shows the geographic impact of Junhui Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junhui Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junhui Sun more than expected).

Fields of papers citing papers by Junhui Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junhui Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junhui Sun. The network helps show where Junhui Sun may publish in the future.

Co-authorship network of co-authors of Junhui Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Junhui Sun. A scholar is included among the top collaborators of Junhui Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junhui Sun. Junhui Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Jiaming, Haiyun Xie, Zixiang Liu, et al.. (2025). KIF26B promotes bladder cancer progression via activating Wnt/β-catenin signaling in a TRAF2-dependent pathway. Cell Reports. 44(5). 115595–115595.
2.
Yang, Yunke, Na Liu, Qingzhe Wu, et al.. (2025). Intratumoral heterogeneity and potential treatment strategies in small cell lung cancer. Frontiers in Oncology. 15. 1657441–1657441.
3.
Huang, Jintao, Bin‐Yan Zhong, Junhui Sun, et al.. (2023). Transarterial Chemoembolization for Patients with Unresectable Hepatocellular Carcinoma with Child-Pugh B7. Journal of Hepatocellular Carcinoma. Volume 10. 1629–1638. 2 indexed citations
4.
Guo, Chengxiang, Jianpeng Sheng, Xing Huang, et al.. (2023). Preoperative sintilimab plus transarterial chemoembolization for hepatocellular carcinoma exceeding the Milan criteria: A phase II trial. Hepatology Communications. 7(3). e0054–e0054. 12 indexed citations
5.
6.
7.
Li, Zhaofeng, Peixin Liu, Wei Chen, et al.. (2023). Hypoxia-cleavable and specific targeted nanomedicine delivers epigenetic drugs for enhanced treatment of breast cancer and bone metastasis. Journal of Nanobiotechnology. 21(1). 221–221. 21 indexed citations
8.
Jin, Zhi‐Cheng, Bin‐Yan Zhong, Jian-Jia Chen, et al.. (2023). Real-world efficacy and safety of TACE plus camrelizumab and apatinib in patients with HCC (CHANCE2211): a propensity score matching study. European Radiology. 33(12). 8669–8681. 49 indexed citations
9.
Peng, Zhenwei, Wenzhe Fan, Bowen Zhu, et al.. (2022). Lenvatinib Combined With Transarterial Chemoembolization as First-Line Treatment for Advanced Hepatocellular Carcinoma: A Phase III, Randomized Clinical Trial (LAUNCH). Journal of Clinical Oncology. 41(1). 117–127. 262 indexed citations breakdown →
10.
Wu, Wei, et al.. (2022). Tumor Response and Nomogram-Based Prognostic Stratification for Hepatocellular Carcinoma After Drug-Eluting Beads Transarterial Chemoembolization. Journal of Hepatocellular Carcinoma. Volume 9. 537–551. 8 indexed citations
11.
Zhong, Bin‐Yan, Zhiping Yan, Junhui Sun, et al.. (2021). Random Survival Forests to Predict Disease Control for Hepatocellular Carcinoma Treated With Transarterial Chemoembolization Combined With Sorafenib. Frontiers in Molecular Biosciences. 8. 618050–618050. 8 indexed citations
12.
13.
Ai, Jing, Sheng-Qun Chen, Feng Chen, et al.. (2020). <p>Gene Therapy with Cytosine Deaminase and Endostatin Fusion Gene Mediated by Endothelial Progenitor Cells in Hepatomas</p>. Cancer Management and Research. Volume 12. 3023–3031. 1 indexed citations
14.
Zhang, Yuelin, Chun‐Hui Nie, Feng Chen, et al.. (2020). Adjuvant Transarterial Chemoembolization for Barcelona Clinic Liver Cancer Stage A Hepatocellular Carcinoma After Hepatectomy. Frontiers in Oncology. 10. 1754–1754. 3 indexed citations
15.
Wang, Jiangang, Songnan Li, Qing Ye, et al.. (2020). Catheter ablation or surgical therapy in moderate-severe tricuspid regurgitation caused by long-standing persistent atrial fibrillation. Propensity score analysis. Journal of Cardiothoracic Surgery. 15(1). 277–277. 12 indexed citations
16.
17.
Dong, Mengjie, Hao Liu, Xili Lu, et al.. (2018). 99mTc-Phy portal perfusion index imaging helps predict the severity of hepatitis B virus cirrhosis. Nuclear Medicine Communications. 39(9). 818–824. 2 indexed citations
18.
Sun, Junhui, Chun‐Hui Nie, Guan‐Hui Zhou, et al.. (2015). Transcatheter Arterial Embolization Alone for Giant Hepatic Hemangioma. PLoS ONE. 10(8). e0135158–e0135158. 49 indexed citations
19.
Sun, Junhui, et al.. (2012). In vitro labeling of endothelial progenitor cells isolated from peripheral blood with superparamagnetic iron oxide nanoparticles. Molecular Medicine Reports. 6(2). 282–286. 15 indexed citations
20.
Sun, Junhui, et al.. (2008). In vivo monitoring of magnetically labeled mesenchymal stem cells intravascularly administered in rat acute renal failure. Swiss Medical Weekly. 138(2728). 404–412. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yoshiyuki Kobayashi Breakdown of academic impact, for papers by Yasuji Ryu Breakdown of academic impact, for papers by Ning Lyu Breakdown of academic impact, for papers by Yasuo Ejima Breakdown of academic impact, for papers by Jiliang Qiu Breakdown of academic impact, for papers by Hanako Tsujikawa Breakdown of academic impact, for papers by Maarten W. Nijkamp Breakdown of academic impact, for papers by Florian Castet Breakdown of academic impact, for papers by Shunli Shen Breakdown of academic impact, for papers by Jimmy Yuen
Rankless by CCL
2026